Orum to participate in Shinhan Bio Forum in Daejeon

Written By Allen (Biho) Seo

Shinhan Securities is hosting an event inviting institutional investors to its biotech forum in Daejeon. During this event, Orum Therapeutics will hold a CEO investor round-table with institutional investors at the Hotel Interciti on July 9th from 4:10 PM to 5:00 PM KST and introduce the company's proprietary degrader-antibody conjugate (DAC) platform and strategic business initiatives.

Allen (Biho) Seo
Previous

Advancing ORM-1153 into the Clinic: Conference Call on IND Clearance & Clinical Study Overview
Next

Orum to participate in KOSDAQ CONNECT 2026